SS
ORIC icon

SBI Securities’s Oric Pharmaceuticals ORIC Stock Holding History

SBI Securities’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25 Hold
2
– – ﹤0.01% 3727
2025
Q4 		$16 Sell
2
-1
-33% -$12 ﹤0.01% 3814
2025
Q3 		$36 Buy
3
+1
+50% +$11 ﹤0.01% 3798
2025
Q2 		$20 Hold
2
– – ﹤0.01% 3916
2025
Q1 		$11 Hold
2
– – ﹤0.01% 3955
2024
Q4 		$16 Buy
+2
New +$18 ﹤0.01% 3873

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

SBI Securities's ORIC Position: Q1 2026 in Review

SBI Securities held its Oric Pharmaceuticals (ORIC) position steady in Q1 2026 at 2 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #3727.

SBI Securities first reported a position in ORIC in Q4 2024 and has held it in 6 quarters since. The position peaked at $36 in Q3 2025. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • SBI Securities held 2 shares of Oric Pharmaceuticals worth $25 as of Q1 2026.
  • SBI Securities left its Oric Pharmaceuticals share count unchanged in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #3727 holding.
  • SBI Securities first reported a position in Oric Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Oric Pharmaceuticals position peaked at $36 in Q3 2025.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.